High-density lipoprotein composition and paraoxonase activity in Type I diabetes
Related Experiment Video
Updated: Aug 8, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
J Valabhji1, A J McColl, M Schachter
1Department of Endocrinology and Metabolic Medicine, Imperial College School of Medicine, St Mary's Hospital, Praed Street, London W2 1NY, UK. j.valabhji@ic.ac.uk
Insights
Type I diabetes increases coronary heart disease (CHD) risk despite normal high-density lipoprotein (HDL) cholesterol. Paraoxonase (PON1) activity in HDL particles did not explain this increased risk in diabetic patients.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Endocrinology
Background:
- Type I diabetes is linked to increased coronary heart disease (CHD) risk, a paradox given normal or elevated high-density lipoprotein (HDL) cholesterol levels.
- Paraoxonase (PON1) activity, an antioxidant enzyme associated with HDL, is hypothesized to influence HDL's protective role against CHD.
Purpose of the Study:
- To investigate the relationship between HDL composition, paraoxonase (PON1) activity, and coronary heart disease (CHD) risk in Type I diabetes.
- To determine if altered PON1 activity in specific HDL fractions contributes to the increased CHD incidence observed in diabetic individuals.
Main Methods:
- Isolated seven HDL fractions from diabetic and non-diabetic subjects using density-gradient ultracentrifugation.
- Measured PON1 activity in serum and isolated HDL fractions using phenyl acetate.
- Assessed CHD risk by measuring carotid artery intima-media thickness (IMT) via B-mode ultrasound.
Main Results:
- Diabetic subjects exhibited increased carotid IMT and higher HDL cholesterol concentrations compared to controls.
- HDL particles in diabetic subjects showed qualitative differences, including reduced triacylglycerol content and increased large, buoyant particles.
- PON1 activity was similar between diabetic and non-diabetic subjects and did not correlate with carotid IMT, suggesting it does not mediate the increased CHD risk.
Conclusions:
- HDL particle density, size, and composition influence PON1 activity.
- Despite altered HDL characteristics in Type I diabetes, PON1 activity does not appear to be a significant factor in the elevated risk of coronary heart disease.
Abstract:
Type I diabetes is associated with a high incidence of coronary heart disease (CHD), despite a normal or even increased concentration of high-density lipoprotein (HDL) cholesterol. This paradox may be explained by changes in the antioxidant capacity of HDL, related to paraoxonase (PON1) activity. HDL compositional changes in subjects with Type I diabetes may result in changes in PON1 activity that are associated with a higher incidence of CHD. Single-vertical-spin density-gradient ultracentrifugation was used to isolate seven HDL fractions from serum according to density. PON1 activity was measured in serum and in the HDL fractions using phenyl acetate as substrate. The mean recovery of PON1 activity in the HDL fractions was 87% (S.D. 12%). CHD risk was assessed using B-mode ultrasound to measure carotid artery intima-media thickness (IMT). Groups of 35 subjects with Type I diabetes [duration of diabetes 18 years (12-32 years) [median (interquartile range)]; glycated haemoglobin 7.67% (1.17%)] and 24 non-diabetic control subjects were studied. Carotid IMT was greater in the diabetic subjects [0.60 (0.55-0.70) compared with 0.55 (0.45-0.64) mm; P=0.042] and HDL cholesterol concentration was higher [1.53 (0.36) compared with 1.32 (0.34) mmol/l; P=0.031]. There were qualitative differences in HDL in subjects with Type I diabetes: HDL particles were triacylglycerol-deplete, and there were greater numbers of the larger, more buoyant HDL particles. These properties were not those found to determine PON1 activity. PON1 activity increased as HDL particle density increased and particle size decreased; the increase in PON1 activity was associated with an increase in the ratio of the two HDL surface lipid components, phospholipid and unesterified cholesterol, as particle density increased. PON1 activity was similar in diabetic and non-diabetic subjects [121 (28) and 120 (36) micromol x min(-1) x ml(-1) respectively; P=0.887]. PON1 activity was not associated with carotid IMT in either group. Our results suggest that the PON1 activities of HDL particles relate to the density, size and composition of the particles. However, PON1 activity does not appear to contribute to the greater risk of CHD in subjects with Type I diabetes.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology

